Dhaliwal A, Armstrong MJ. Sarcopenia in cirrhosis: a practical overview. Clin Med (Lond) 2020;20(5):489–492. DOI: 10.7861/clinmed.2020-0089
Tantai X, Liu Y, Yeo YH, et al. Effect of sarcopenia on survival in patients with cirrhosis: a meta-analysis. J Hepatol 2022;76(3):588–599. DOI: 10.1016/j.jhep.2021.11.006
Mattoo R, Gupta A, Sharma R, et al. To study the prevalence of sarcopenia in patients with cirrhosis and its impacts on outcomes. J Postgrad Med Edu Res 2024:58(4):157–162.
Cui Y, Zhang M, Guo J, et al. Correlation between sarcopenia and cirrhosis: a meta-analysis. Front Nutr 2024;10:1342100. DOI: 10.3389/fnut.2023.1342100
Kim G, Kang SH, Kim MY, et al. Prognostic value of sarcopenia in patients with liver cirrhosis: a systematic review and meta-analysis. PLoS One 2017;12(10):e0186990. DOI: 10.1371/journal.pone.0186990
Choudhary S, Wadhawan M, Dhawan S, et al. Normative values of skeletal muscle indices for nutritional assessment and implications on definition of sarcopenia in Indian adult population. Indian J Gastroenterol 2022;41(1):69–76. DOI: 10.1007/s12664-021-01207-2
Zeng X, Shi ZW, Yu JJ, et al. Sarcopenia as a prognostic predictor of liver cirrhosis: a multicentre study in China. J Cachexia Sarcopenia Muscle 2021;12(6):1948–1958. DOI: 10.1002/jcsm.12797
Montano-Loza AJ, Duarte-Rojo A, Meza-Junco J, et al. Inclusion of sarcopenia within MELD (MELD-sarcopenia) and the prediction of mortality in patients with cirrhosis. Clin Transl Gastroenterol 2015;6(7):e102. DOI: 10.1038/ctg.2015.31
Mazeaud S, Zupo R, Couret A, et al. Prevalence of sarcopenia in liver cirrhosis: a systematic review and meta-analysis. Clin Transl Gastroenterol 2023;14(7):e00584. DOI: 10.14309/ctg.0000000000000584
Di Cola S, Khan S, Lapenna L, et al. Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver. Expert Opin Emerg Drugs 2024;29(2):81–91. DOI: 10.1080/14728214.2024.2332428
